The Valley Desk

NCT00371345 · Interventional trial

Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer

Overall registry status Completed

Phase 2

Conditions Breast Cancer, Metastasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov